Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Nov;45(5):559-71.
doi: 10.2144/000112960.

Improvements to bead-based oligonucleotide ligation SNP genotyping assays

Affiliations

Improvements to bead-based oligonucleotide ligation SNP genotyping assays

Shannon Bruse et al. Biotechniques. 2008 Nov.

Abstract

We describe a bead-based, multiplexed, oligonucleotide ligation assay (OLA) performed on the Luminex flow cytometer. Differences between this method and those previously reported include the use of far fewer beads and the use of a universal oligonucleotide for signal detection. These innovations serve to significantly reduce the cost of the assay, while maintaining robustness and accuracy. Comparisons are made between the Luminex OLA and both pyrosequencing and direct sequencing. Experiments to assess conversion rates, call rates, and concordance across technical replicates are also presented.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Overview of Luminex OLA assay
The assay consists of four steps; 1) Multiplexed PCR 2) multiplexed OLA 3) hybridization with beads and SAPE 4) Detection using the Luminex flow cytometer. Steps 2–4 take place in the same 96-well plate.
Figure 2
Figure 2. Genotype clusters for 15-plex assay
Individual figures represent the allelic ratios (X axis) produced from a first pass genotyping of 750 human genomic DNA samples (Y axis). Variability in allelic ratios is observed for different SNP assays, generally with skewing of heterozyote clusters, though homozygote clusters can also be skewed (i.e. rs9606240). Nonetheless, for each SNP genotype clusters are robust (see Table 4 for silhouette scores).
Figure 3
Figure 3. Raw data of 4 representative SNP assays
Each scatterplot represents the median fluorescence intensity (MFI) of allele 1 and allele 2 for four SNPs. The scatterplots represent the raw data from which allelic ratios (figure 2) were calculated.

Similar articles

Cited by

References

    1. Giacomini KM, et al. The pharmacogenetics research network: from SNP discovery to clinical drug response. Clin Pharmacol Ther. 2007;81(3):328–345. - PMC - PubMed
    1. Thomas FJ, McLeod HL, Watters JW. Pharmacogenomics: the influence of genomic variation on drug response. Curr Top Med Chem. 2004;4(13):1399–1409. - PubMed
    1. Gunderson KL, et al. Whole-genome genotyping. Methods Enzymol. 2006;410:359–376. - PubMed
    1. Kennedy GC, et al. Large-scale genotyping of complex DNA. Nat Biotechnol. 2003;21(10):1233–1237. - PubMed
    1. Alderborn A, Kristofferson A, Hammerling U. Determination of single-nucleotide polymorphisms by real-time pyrophosphate DNA sequencing. Genome Res. 2000;10(8):1249–1258. - PMC - PubMed

Publication types

LinkOut - more resources